Since the balance between CD47 and ecto-CRT expression determines the susceptibility of cancer cells to engulfment by phagocytes, based on our results (Figures 2C,D), we hypothesized that gefitinib treatment could promote phagocytosis of NSCLC cells by CD47 down-regulation. The gene discussed is CALR; the disease is non-small cell lung carcinoma.